The upregulation of CYP1B1 and its cardiotoxic metabolites, midchain HETEs, is a prevalent feature in various diseases and conditions, including inflammation, cancer, and cardiac hypertrophy (Li et al., 2017). This evidence concerns the gene CYP1B1 and cardiac hypertrophy.